Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China |
Paroxysmal Nocturnal Hemoglobinuria | China | NCT06931691 | |
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Argentina Canada China Czechia France Germany Hungary Italy Japan Netherlands Poland Slovakia South Korea Spain Taiwan United Kingdom United States View all |
NCT06947993 |
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) |
Lupus Nephritis | Phase3 | China Colombia Hungary Mexico Singapore South Korea Taiwan Thailand View all |
NCT06711887 |
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET |
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) | Phase3 | Canada China France Germany Hungary Italy Netherlands Poland South Korea Spain United States View all |
NCT06784752 |
RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL) |
Chronic Myelogenous Leukemia in Chronic Phase | Saudi Arabia | NCT06684964 | |
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria |
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Phase2 | France Germany Poland Spain United States View all |
NCT06865651 |
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients |
Hypertension | Phase2 | Japan Singapore United States |
NCT06857955 |
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. |
Chagas Disease | Phase2 | Argentina Brazil Colombia United States View all |
NCT06632600 |
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas |
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer | Phase1, Phase2 | France Italy Poland South Korea Spain United Kingdom United States View all |
NCT04104776 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Early Breast Cancer | Phase3 | Australia Canada China Germany Hong Kong India Israel Mexico Portugal Puerto Rico South Korea Taiwan Turkey (Türkiye) United States View all |
NCT05827081 |